ConductScience.org, home

Trial · NCT04537078

Results by group28

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
the Number of M2 Oocytes Retrievedthe Progestin Primed Double Stimulation Group6Inter-Quartile Range 3 to 7oocytes
the Number of M2 Oocytes Retrievedthe Flexible GnRh Antagonist Group4.5Inter-Quartile Range 3 to 8oocytes
the Fertilization Ratethe Progestin Primed Double Stimulation Group71.43Inter-Quartile Range 66.67 to 100percentage of transformation
the Fertilization Ratethe Flexible GnRh Antagonist Group80.91Inter-Quartile Range 66.67 to 100percentage of transformation
the Resultant Embryos Numberthe Progestin Primed Double Stimulation Group4Inter-Quartile Range 3 to 5number of embryos
the Resultant Embryos Numberthe Flexible GnRh Antagonist Group3Inter-Quartile Range 2 to 6number of embryos
the Implantation Ratethe Progestin Primed Double Stimulation Group50Inter-Quartile Range 50 to 100percentage
the Implantation Ratethe Flexible GnRh Antagonist Group50Inter-Quartile Range 33.33 to 50percentage
the Clinical Pregnancy Rate.the Progestin Primed Double Stimulation Group7percentage of participants
the Clinical Pregnancy Rate.the Flexible GnRh Antagonist Group8percentage of participants
the Difference in the Ongoing Pregnancy Rate in Both Protocols.the Progestin Primed Double Stimulation Group6percentage of participants
the Difference in the Ongoing Pregnancy Rate in Both Protocols.the Flexible GnRh Antagonist Group5percentage of participants
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Days of Controlled Ovarian Hyperstimulationthe Follicular Phase of the Progestin Primed Double Stimulation Group10Inter-Quartile Range 9 to 12number of days
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Days of Controlled Ovarian Hyperstimulationthe Luteal Phase of the Progestin Primed Double Stimulation Group12Inter-Quartile Range 10 to 13number of days
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Dosage of Gonadotropins Used in the Controlled Ovarian Hyperstimulation
the Follicular Phase of the Progestin Primed Double Stimulation Group3000Inter-Quartile Range 2700 to 3150IU
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Total Dosage of Gonadotropins Used in the Controlled Ovarian Hyperstimulation
the Luteal Phase of the Progestin Primed Double Stimulation Group3600Inter-Quartile Range 3000 to 3750IU
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Number of M2 Oocytes Retrievedthe Follicular Phase of the Progestin Primed Double Stimulation Group2Inter-Quartile Range 1 to 3number of oocytes
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Number of M2 Oocytes Retrievedthe Luteal Phase of the Progestin Primed Double Stimulation Group4Inter-Quartile Range 2 to 5number of oocytes
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Fertilization Rate.the Follicular Phase of the Progestin Primed Double Stimulation Group66.67Inter-Quartile Range 50 to 100percentage
the Difference Between the Follicular Phase and the Luteal Phase of the Progestin Primed Double Stimulation Protocol Regarding the Fertilization Rate.the Luteal Phase of the Progestin Primed Double Stimulation Group100Inter-Quartile Range 60 to 100percentage

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04537078/results